1
Enquiry period
with 26.07.2024 17:45
to 05.08.2024 14:30
2
Bidding period
with 05.08.2024 14:30
to 10.09.2024 14:00
2 days left
3
Auction
will not be used
4
Evaluation

5
Contract

Status Bidding period
Estimated value without VAT 107 168 369,63 MDL
Period of clarifications: 26 Jul 2024, 17:45 - 5 Aug 2024, 14:30
Submission of proposals: 5 Aug 2024, 14:30 - 10 Sep 2024, 14:00

Supplier technical support:

(+373) 79999801


This procedure is carried out without auction. Your offer is final and must contain the entire list of required documents.

Subscribe

“Achiziționarea medicamentelor oncologice şi imunosupresive necesare instituţiilor medico-sanitare publice (IMSP) pentru anul 2025”

Information about customer
Fiscal code/IDNO
Address
MD-2005, MOLDOVA, mun.Chişinău, locality, mun. Chișinău MD-2005, bd. Grigore Vieru, 22/2
Web site
---
The contact person
Full name
Macari Doina
Contact phone
+37322222490
Purchase data
Date created
26 Jul 2024, 17:26
Date modified
2 Aug 2024, 13:43
Achizitii.md ID
21263466
CPV
33600000-6 - Produse farmaceutice
Type of procedure
Open tender
Award criteria
The lowest price
Funding sources
List of lots
Lot nr. 5 - Azathioprinum 50 mg
Budget: 1956.12 MDL
Active
Lot nr. 6 - Basiliximabum 20mg+5ml
Budget: 252648.62 MDL
Active
Lot nr. 10 - Bicalutamidum 150 mg
Budget: 390355.56 MDL
Active
Lot nr. 11 - Bicalutamidum 50 mg
Budget: 280208.33 MDL
Active
Lot nr. 12 - Bleomycinum 15 UI
Budget: 215020.94 MDL
Active
Lot nr. 15 - Capecitabinum 500 mg
Budget: 2253948.89 MDL
Active
Lot nr. 26 - Dacarbazinum 200 mg
Budget: 129043.3 MDL
Active
Lot nr. 35 - Epirubicinum 10 mg
Budget: 517687.5 MDL
Active
Lot nr. 41 - Gemcitabinum 1000 mg
Budget: 1682033.88 MDL
Active
Lot nr. 43 - Ibrutinibum 140 mg
Budget: 17602914 MDL
Active
Lot nr. 45 - Ifosfamidum 1000 mg
Budget: 230208.15 MDL
Active
Lot nr. 46 - Ifosfamidum 500 mg
Budget: 41246.8 MDL
Active
Lot nr. 50 - Leuprorelinum 3.75 mg
Budget: 154347.59 MDL
Active
Lot nr. 53 - Mesnum 400mg/4ml
Budget: 154440 MDL
Active
Lot nr. 55 - Mitomycinum 20 mg
Budget: 105106.58 MDL
Active
Lot nr. 59 - Oxaliplatinum 100 mg
Budget: 1104960.74 MDL
Active
Lot nr. 65 - Pemetrexedum 100 mg
Budget: 617674.42 MDL
Active
Lot nr. 66 - Pemetrexedum 500 mg
Budget: 364961.24 MDL
Active
Lot nr. 71 - Tacrolimus 5 mg
Budget: 6031.7 MDL
Active
Lot nr. 72 - Tegafurum 400 mg
Budget: 183720 MDL
Active
Lot nr. 73 - Temozolomidum 100 mg
Budget: 282714.44 MDL
Active
Lot nr. 76 - Temozolomidum 5 mg
Budget: 13790.4 MDL
Active
Lot nr. 78 - Tioguaninum 40 mg
Budget: 40292.59 MDL
Active
Lot nr. 80 - Trastuzumabum 150 mg
Budget: 4911887.69 MDL
Active
Lot nr. 83 - Vemurafenib 240 mg
Budget: 9531289.19 MDL
Active
Lot nr. 84 - Vinblastinum 10 mg
Budget: 87612.74 MDL
Active
Documents of the procurement procedure
Scrisoare de garantie bancara_Model
Bidding Documents
Scrisoare de garantie bancara_Model
26.07.24 17:45
Documentatia standard.signed
Bidding Documents
Documentatia standard.signed
26.07.24 17:45
Declaratie beneficiari efectivi_Model
Bidding Documents
Declaratie beneficiari efectivi_Model
26.07.24 17:45
DUAE Model
Bidding Documents
DUAE Model
26.07.24 17:45
Declaratie privind valabilitatea ofertei_Model
Bidding Documents
Declaratie privind valabilitatea ofertei_Model
26.07.24 17:45
Cerere de participare_Model
Bidding Documents
Cerere de participare_Model
26.07.24 17:45
Propunerea tehnică
Technical Specifications
Propunerea tehnică
26.07.24 17:45
Lista de distributie_Med onco si imunosupresive pu 2025
Bidding Documents
Lista de distributie_Med onco si imunosupresive pu 2025
30.07.24 16:24
Anunt de participare Onco din 02.08.2024.signed
Bidding Documents
Anunt de participare Onco din 02.08.2024.signed
2.08.24 13:43
Anunt de participare din 19.08.2024 Onco.signed.pdf
Bidding Documents
Anunt de participare din 19.08.2024 Onco.signed.pdf
20.08.24 09:11
Propunerea financiară din 19.08.2024.xlsx
Bidding Documents
Propunerea financiară din 19.08.2024.xlsx
20.08.24 09:11
Contract model din 19.08.2024.docx
Bidding Documents
Contract model din 19.08.2024.docx
20.08.24 09:12
Only authorized platform users may ask questions during the clarification period.